Brief: Kintor Pharma Announces Inclusion In MSCI China Index
15/05/2022 11:32
May 15 (Reuters) - Kintor Pharmaceutical Ltd 9939.HK :
* KINTOR PHARMA INCLUDED IN MSCI CHINA INDEX
* CO'S STOCK HAS BEEN INCLUDED IN THE MSCI CHINA INDEX,
EFFECTIVE
MAY 31, 2022
Source text for Eikon: ID:nPn7pRJHRa
Further company coverage: 9939.HK
((reuters.briefs@thomsonreuters.com;))
Recent news on Kintor Pharmaceutical
See all newsBrief: Kintor Pharmaceutical Receives Invention Patent Grant For KT-939 In China
Brief: Kintor Pharmaceutical Says Ming Ming Cheung Resigns As CFO
Brief: Kintor Pharmaceutical Says CEO Via Wholly Owned Co Increases Shareholding By 2.51 Million Shares
Brief: Kintor Pharmaceutical Says YTD 2026 Sales Revenue At RMB34 Million
Brief: Kintor Pharmaceutical Says Pharma's Kx-826 Phase Iii Trial In China Reaches Primary Endpoint